Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ – STARS Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Covidien PLC Comments On FY 2014 Revenue Guidance

Thursday, 12 Sep 2013 04:00pm EDT 

Covidien PLC announced that for fiscal 2014. The Company estimates that net sales to increase 2% to 5% versus 2013 net sales. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $10.653 billion for fiscal 2014. 

Company Quote

0.37 +0.41%
11 Jul 2014